LAURA WILLIAMS: Open Payments
NPI 1992891055 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,002 in 40 payments from 7 companies in 2025. Trend: 2023 $490 · 2024 $734 · 2025 $1,002
Food & beverage: $1,002
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $265 |
| Madrigal Pharmaceuticals | 4 | $241 |
| PFIZER INC. | 9 | $178 |
| Gilead Sciences, Inc. | 1 | $135 |
| Melinta Therapeutics, LLC | 1 | $107 |
| Phathom Pharmaceuticals, Inc. | 3 | $42 |
| Ardelyx, Inc. | 2 | $33 |
Products named: REZDIFFRA, XELJANZ, Livdelzi, RINVOQ, Kimyrsa, SKYRIZI, LINZESS, VOQUEZNA.
Industry payments across FL — which companies pay providers there.
